Reggiolo, Italy

Dario Bosi


 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dario Bosi: Innovator in Iron Therapy

Introduction

Dario Bosi is a notable inventor based in Reggiolo, Italy. He has made significant contributions to the field of iron therapy, particularly in the treatment of hyposideremia and anemia. With a total of 2 patents, his work focuses on innovative formulations and methods for iron administration.

Latest Patents

Dario Bosi's latest patents include a new modus of administration of iron and new formulations adapted for this goal. His first patent addresses a new regimen of administration of divalent iron, which aims to reduce toxic side effects while effectively treating hyposideremia. The formulations are designed to facilitate intrabuccal absorption, preferably through sublingual methods, ensuring efficient iron release.

His second patent introduces low molecular weight complexes between iron and maltobionic acid. These complexes are intended for parenteral administration, specifically intramuscularly or subcutaneously, to treat anemic states caused by iron deficiencies. The invention details a new complex characterized by a molecular weight between 10,000 and 30,000 Da, a polydispersity of 1.0-1.8, and an iron content ranging from 25% to 40% by weight.

Career Highlights

Dario Bosi is associated with Biofer S.p.a., where he continues to develop innovative solutions in iron therapy. His work has garnered attention for its potential to improve patient outcomes in the treatment of anemia.

Collaborations

Dario collaborates with notable colleagues, including Alessandro Lapini Sacchetti and Egidio Marchi. Their combined expertise contributes to the advancement of research and development in the field of iron therapy.

Conclusion

Dario Bosi's contributions to iron therapy through his innovative patents highlight his commitment to improving treatment options for patients with iron deficiencies. His work continues to pave the way for advancements in pharmaceutical formulations and administration methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…